Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17109348 | PREPARATION OF DNA SEQUENCING LIBRARIES FOR DETECTION OF DNA PATHOGENS IN PLASMA | December 2020 | June 2024 | Abandon | 43 | 3 | 1 | No | No |
| 17058066 | Methods of Producing Nucleic Acid Libraries and Compositions and Kits for Practicing Same | November 2020 | February 2023 | Allow | 27 | 1 | 1 | No | No |
| 17089432 | PROBE FOR DETECTING HEPATITIS B VIRUS AND USE THEREOF | November 2020 | August 2023 | Allow | 33 | 1 | 1 | No | No |
| 17071917 | METHODS OF IDENTIFYING MULTIPLE EPITOPES IN CELLS | October 2020 | April 2024 | Allow | 42 | 0 | 1 | No | No |
| 17045066 | DEGRADABLE CARRIER NUCLEIC ACID FOR USE IN THE EXTRACTION, PRECIPITATION AND/OR PURIFICATION OF NUCLEIC ACIDS | October 2020 | May 2024 | Abandon | 44 | 1 | 1 | No | No |
| 16980721 | HIGH THROUGHPUT METHOD OF PERSONALIZED TARGET ENRICHMENT PANEL ASSEMBLY | September 2020 | October 2023 | Abandon | 38 | 0 | 1 | No | No |
| 17017483 | CYCLONE ROLLING CIRCLE AMPLIFICATION, DOUBLE PRIMER FOR ROLONY AND REPLI-ROLONY AND PAIR-END SEQUENCING PROCESS | September 2020 | May 2023 | Abandon | 33 | 0 | 1 | No | No |
| 17004403 | PROTEIN SURFACE RECOGNITION VIA CHEMICALLY ENHANCED PHAGE DISPLAY | August 2020 | December 2023 | Allow | 39 | 2 | 1 | No | No |
| 16999993 | LIGATION MEDIATED ANALYSIS OF NUCLEIC ACIDS | August 2020 | April 2023 | Abandon | 31 | 1 | 0 | No | No |
| 16944185 | METHOD FOR ANALYZING AN INTERACTION EFFECT OF NUCLEIC ACID SEGMENTS IN NUCLEIC ACID COMPLEX | July 2020 | March 2023 | Abandon | 32 | 0 | 1 | No | No |
| 16919500 | TIM-3 NANOBODY, A PREPARATION METHOD THEREOF, AND USE THEREOF | July 2020 | September 2023 | Allow | 38 | 2 | 1 | No | No |
| 16632268 | IMPROVED METHOD AND KIT FOR THE GENERATION OF DNA LIBRARIES FOR MASSIVELY PARALLEL SEQUENCING | January 2020 | August 2023 | Allow | 43 | 1 | 1 | No | No |
| 16564135 | Method For Detecting Activity Change Of Transposon In Plant Before And After Stress Treatment | September 2019 | March 2023 | Abandon | 42 | 1 | 0 | No | No |
| 16146901 | ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN SEQUENCING LIBRARY PREPARATION | September 2018 | August 2023 | Allow | 58 | 3 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner BEIL, RANDI LYNN works in Art Unit 1675 and has examined 14 patent applications in our dataset. With an allowance rate of 50.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.
Examiner BEIL, RANDI LYNN's allowance rate of 50.0% places them in the 13% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BEIL, RANDI LYNN receive 1.14 office actions before reaching final disposition. This places the examiner in the 11% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by BEIL, RANDI LYNN is 39 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
When applicants file an RCE with this examiner, 33.3% of applications are subsequently allowed. This success rate is in the 73% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 50.0% of cases where such amendments are filed. This entry rate is in the 75% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants file petitions regarding this examiner's actions, 120.0% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.